Subscribe To Our Newsletter
Abonnez-vous à notre bulletin
U.N. General Assembly’s high-level meeting on TB called on leaders to reaffirm commitment to end tuberculosis by 2030
GFO Issue 343

U.N. General Assembly’s high-level meeting on TB called on leaders to reaffirm commitment to end tuberculosis by 2030


Tinatin Zardiashvili

Article Type:

Article Number: 2

Political declaration sets ambitious targets for investment and progress monitoring

ABSTRACT The United Nations General Assembly held its first High-level Meeting on Tuberculosis, to reaffirm Member States’ commitments to accelerating collaborative efforts to end the disease. Member States endorsed the ‘Political Declaration on TB’ calling for accelerated and concerted efforts against the disease.

On September 26, in New York, the U.N. General Assembly hosted a first ever high-level meeting (HLM) on tuberculosis under the key theme – “United to end tuberculosis: an urgent global response to a global epidemic”. The purpose of the meeting was to provide a platform for high-level leaders to reaffirm their commitment to accelerate efforts towards the goal of ending the TB epidemic by 2030.

Up to 40 Member States, represented by heads of state, health ministers, parliamentarians and city mayors, attended the meeting along with leaders of civil society organizations, TB survivors, business and research organizations, international development agencies and donors such as WHO, UNICEF, the World Bank, the Global Fund to Fight AIDS, TB and Malaria, UNITAID, and the Bill & Melinda Gates Foundation, among others.

The main outcome of the HLM was Member States’ endorsement of the ‘Political Declaration on TB’, committing them to greater efforts and investments towards the Sustainable Development Goals’ target of ending the TB epidemic by 2030.

The resolution calls for increased political commitment at the national, regional and global levels, and for increased investments in TB programs, research and innovations, with ambitious targets to treat up to 40 million patients by 2022 and mobilize sufficient and sustainable financing to enable timely prevention, screening, diagnostics, treatment and care for all people affected by TB.

The declaration states that “while the World Health Organization declared tuberculosis a global emergency 25 years ago, it is still among the top ten causes of death worldwide”.

Although all UN Member States have already committed to end TB by 2030, through their endorsement of the “End TB Strategy” adopted at the World Health Assembly in 2014, progress in the fight against the disease has been slower than hoped, making the 2030 target, which is aligned with the Sustainable Development Goals, difficult to attain. This was confirmed by WHO’s latest annual Global Tuberculosis Report, released on 18 September 2018, in time for the High Level Meeting. The report states that 1.6 million people died of TB in 2017 (including 300,000 deaths among HIV-positive people)  while the annual financial gap in financing treatment and services for TB was estimated at $13 billion.

Drug-resistant TB is already a public health crisis and a rising threat, with almost half of drug-resistant tuberculosis cases, the TB report says, found in three countries: India (24%), China (13%), and Russia (10%).

The report also stressed the sizeable deficit in funding of TB-related research, amounting to $1.3 billion. According to the report, in 2017 an estimated 10 million people developed tuberculosis, and 4 million people with tuberculosis remained undiagnosed and untreated. Two-thirds of this global tuberculosis case burden of 10 million cases was found in eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%), and South Africa (3%).”

The meeting included a plenary segment for general discussion and two multi-stakeholder panels on how to scale up efforts to improve access to treatment and prevention services and financing and process, research and commitment to innovations.

The core themes of the HLM discussions and the meeting’s expected outcomes were drawn from civil society hearings that were organized in preparation for HLM, in June 2018. Around 400 participants from civil society and the private sector, parliamentarians, NGOs, academia, medical associations and patients voiced their opinions and discussed potential solutions. The summary of the hearing informed the ‘Key Asks from TB Stakeholders and Communities’ document describing expected outcomes of the meeting, which are to:

  1. Reach all people by closing the gaps in TB diagnosis, treatment and prevention
  2. Transform the TB response to be equitable, rights-based, and people-centered
  3. Accelerate development of essential new tools to end TB
  4. Invest the funds necessary to end TB
  5. Commit to decisive and accountable global leadership, including regular UN reporting and review.


The director-general of WHO was requested to develop the Multisectoral Accountability Framework by 2019, to measure progress against targets. The U.N. Secretary General, with support of the WHO, will commission progress reports at national and global levels for 2020. The next high-level meeting on TB, planned for 2023, will provide a comprehensive review of results.

Since 2002, the Global Fund has invested more than US$6.2 billion in the fight against TB and now represents about 65 percent of the international funding response to TB.

Some stakeholders were dissatisfied with the meeting’s outcome. Health Gap along with seven other TB-related NGOs issued a joint statement on 26 September, called ‘What is Missing from the United Nations Political Declaration on Tuberculosis?’ saying thatthe declaration falls short in its response to the leading infectious killer worldwide and the leading cause of death for people with HIV around the world.”

The NGOs collectively commit to taking 12 “concrete steps” in pursuit of ending the TB epidemic, including an appeal to the Global Fundto launch immediately a reprogramming and fundraising initiative to ensure high-TB burden countries modify their Global Fund-funded TB and TB-HIV programs to reflect the newest WHO treatment and prevention guidelines rather than old and outmoded approaches.”

In an email to Aidspan, the Global Fund’s Head of Communications, Seth Faison, responded to the Health Gap Declaration with the following comment:

“The Global Fund fully supports action that increases and expands programs aimed at ending TB. It is critically important to support efforts in high-TB burden countries to find and treat the missing cases, and to adopt the most effective and up-to-date treatment and prevent guidelines. We strongly encourage reprogramming that makes TB treatment and prevention more effective, and we welcome work by all partners to raise more money to fight TB.”

For more information on the UNGA’s High-level meeting on TB, see also:

–       The ‘Key Asks from TB Stakeholders and Communities’ preparatory document for the HLM

–       The modalities resolution adopted in April, 2018, which defined the scope, format and agenda of the HLM

–       The videos of opening and plenary segments here

–       The electronic versions of the country statements can be downloaded from Paper Smart Services

–       The Global Fund’s 19 September statement, ‘More Urgency, New Funding Needed to End TB’

–       The Global Fund’s 26 September statement, ‘Global Fund Supports Brave Commitments to Ending TB’

Leave a Reply

Your email address will not be published.